Printer Friendly
The Free Library
19,604,538 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Celera Diagnostics Announces Availability of Video Footage in Conjunction With Announcement of Alliance With Abbott Laboratories.


Business Editors/Health & Medical Writers

BIOWIRE2K

NOTE TO MEDIA: Multimedia assets available

Visit Newstream.com and Applera.com to View

Footage of Celera Diagnostics

Celera Diagnostics, a joint venture between the Applied Biosystems Group (NYSE NYSE

See: New York Stock Exchange
:ABI Abi (ā`bī) [short for Abijah], in the Bible, King Hezekiah's mother.


(Application Binary Interface) A specification for a specific hardware platform combined with the operating system.
), and the Celera Genomics Group (NYSE:CRA See Community Reinvestment Act. ) of Applera Corporation, today announced the availability of video footage in conjunction with its long-term strategic alliance with Abbott Laboratories (NYSE:ABT ABT About
ABT Abteilung (German: Department)
ABT Abbott Laboratories (stock symbol)
ABT American Ballet Theatre
ABT Associação Brasileira de Telemarketing
ABT Abort
ABT Availability Based Tariff
) to develop, manufacture and market a broad range of in vitro molecular diagnostic products for disease detection, disease progression monitoring and therapy selection.

The video footage can be viewed by visiting newstream.com or by visiting www.applera.com and clicking on the "Celera Diagnostics" link.

About Celera Diagnostics and Applera Corporation

Celera Diagnostics is a joint venture between two Applera Corporation businesses, Applied Biosystems and Celera Genomics. Headquartered in Alameda, CA, Celera Diagnostics focuses on discovering novel genetic markers for disease and configuring these into new diagnostic tests to predict, characterize, monitor and select therapy for cardiovascular disease, auto-immunity, central nervous system disorders Nervous system disorders

A satisfactory classification of diseases of the nervous system should include not only the type of reaction (congenital malformation, infection, trauma, neoplasm, vascular diseases, and degenerative, metabolic, toxic, or deficiency
, and cancer. The Applied Biosystems Group develops and markets instrument-based systems, reagents, software, and contract services to the life science industry and research community. Customers use these tools to analyze nucleic acids (DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
 and RNA RNA: see nucleic acid.
RNA
 in full ribonucleic acid

One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic
), small molecules, and proteins to make scientific discoveries, leading to the development of new pharmaceuticals, and to conduct standardized testing. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.6 billion during fiscal 2001. The Celera Genomics Group, located in Rockville, MD, and South San Francisco South San Francisco, city (1990 pop. 54,312), San Mateo co., W Calif.; inc. 1908. South San Francisco has several industrial parks; its manufactures include medical supplies and equipment, foods, paint, paper products, consumer goods, and clothing. , CA, is engaged principally in integrating advanced technologies to discover and develop new therapeutics. Celera intends to leverage its genomic and proteomic technology platforms to identify drug targets and diagnostic marker candidates, and to discover novel therapeutic candidates. Its Celera Discovery System(TM) online platform, to be marketed exclusively through the Knowledge Business of Applied Biosystems, is an integrated source of information based on the human genome and other biological and medical sources. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at www.applera.com, or by telephoning 800/762-6923.

NOTE TO MEDIA: A video relating to this story will be available for journalists to download beginning today at www.newstream.com and at www.businesswire.com
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jun 24, 2002
Words:384
Previous Article:Metropolitan Joins Local Agencies in Signing Agreement for Long Beach Groundwater Storage Project; Project is the First in Southern California to...
Next Article:Moody's Corporation to Present at William Blair & Co. Conference on June 26, 2002.
Topics:



Related Articles
Multimedia Available: Celera Diagnostics Announces Availability of Video Footage In Conjunction With Announcement of Alliance With Abbott...
Celera Diagnostics Gains Additional FDA Clearance for ViroSeq HIV-1 Genotyping System.
Applied Biosystems/MDS Sciex and Dionex Corporation Announce an Alliance to Jointly Develop and Market Analytical Solutions for Emerging Markets...
Celera Genomics Acquires Full Ownership of Celera Diagnostics Joint Venture; Celera Genomics to Partner or Sell Small Molecule Drug Development...
Applied Biosystems Transfers Its Interest in Celera Diagnostics to Celera Genomics in Exchange for Various Considerations and Cash.
Applera and Beckman Coulter Announce Terms of Settlement of Legal Disputes.
Applera and Beckman Coulter Announce Final Agreement on Settlement.
Celera Genomics Receives NIH Grant to Develop and Commercialize Avian Flu Diagnostic Test.
Celera Genomics Reports First Quarter Fiscal 2007 Results.
Hospitals, Healthcare Providers to Save with Premier Core Laboratory Products Agreements.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles